GLPG
Galapagos NV ADR
NASDAQ: GLPG · HEALTHCARE · BIOTECHNOLOGY
$27.86
-1.97% today
Updated 2026-04-29
Market cap
$1.91B
P/E ratio
5.00
P/S ratio
1.72x
EPS (TTM)
$5.69
Dividend yield
—
52W range
$25 – $38
Volume
0.2M
Galapagos NV ADR (GLPG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
28.80%
Operating margin
88.00%
ROE
10.40%
ROA
8.87%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $35.15M | $-11.34M | 44.43% | -33.59% | -32.25% |
| 2007 | $65.94M | $-21.95M | 54.25% | -33.12% | -33.29% |
| 2008 | $76.98M | $-14.58M | 63.93% | -19.77% | -18.95% |
| 2009 | $93.09M | $3.01M | 8.59% | 1.78% | 3.23% |
| 2010 | $122.41M | $4.37M | 5.22% | 0.84% | 3.57% |
| 2011 | $95.89M | $-33.10M | -30.35% | -34.35% | -34.52% |
| 2012 | $136.27M | $-5.72M | 64.64% | -4.85% | -4.20% |
| 2013 | $137.70M | $-8.08M | 70.01% | -8.00% | -5.87% |
| 2014 | $69.37M | $33.21M | -60.17% | -52.80% | 47.88% |
| 2015 | $39.56M | $-118.41M | -227.87% | -226.08% | -299.29% |
| 2016 | $129.52M | $54.01M | -7.77% | -8.87% | 41.70% |
| 2017 | $127.09M | $-115.70M | -71.93% | -70.66% | -91.04% |
| 2018 | $288.84M | $-29.26M | -11.79% | -15.51% | -10.13% |
| 2019 | $834.90M | $149.84M | 49.68% | 44.17% | 17.95% |
| 2020 | $478.05M | $-305.44M | -9.54% | -37.37% | -63.89% |
| 2021 | $484.85M | $-125.42M | 99.66% | -34.15% | -25.87% |
| 2022 | $241.25M | $-217.99M | 100.00% | -54.32% | -90.36% |
| 2023 | $239.72M | $211.70M | 100.00% | -36.82% | 88.31% |
| 2024 | $275.65M | $74.08M | 87.35% | -68.33% | 26.88% |
| 2025 | $1.11B | $320.90M | 56.02% | 45.08% | 28.85% |